Key facts
- This page summarizes Derek Jantz's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Jun 2022, 16:42.
Derek Jantz - 07 Jun 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)
- Reporting relationship
- Chief Scientific Officer, Director
- Issuer ticker
- DTIL
- Reported as of
- 07 Jun 2022
- Net transaction value
- -$38,829
- SEC form
- 4
- Accepted by SEC
- 09 Jun 2022, 16:42:23 UTC
- Prior SEC filing
- 07 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Alexander Kelly, Attorney-in-Fact for Derek Jantz
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Derek Jantz filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 09 Jun 2022.
Change
- Previous filing in this sequence was filed on 07 Mar 2022.
- Current net transaction value: -$38,829.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DTIL
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +29,545
- Change %
- +0.73%
- Price
- Shares after
- 4,061,824
- Date
- 07 Jun 2022
- Ownership
- Direct
- Footnotes
- F1, F2
DTIL
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +12,199
- Change %
- +0.3%
- Price
- Shares after
- 4,074,023
- Date
- 07 Jun 2022
- Ownership
- Direct
- Footnotes
- F1, F2
DTIL
transaction
Common Stock
Sale
- Transaction value
- $38,829
- Shares
- -18,849
- Change %
- -0.46%
- Price
- $2.06
- Shares after
- 4,055,174
- Date
- 08 Jun 2022
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DTIL
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -29,545
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 29,545
- Date
- 07 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 29,545
- Exercise price
- Footnotes
- F2, F4
DTIL
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -12,199
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 24,391
- Date
- 07 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,199
- Exercise price
- Footnotes
- F2, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.
Footnote F2
Each RSU represents a contingent right to receive one share of the Company's Common Stock.
Footnote F3
The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
Footnote F4
On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Footnote F5
On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.